The team, from biopharmaceutical company Regeneron, hopes their work will help researchers better understand protein-protein interactions during preclinical development of a drug. “Essentially, we ...

Abstract: Deep learning-based methods for drug target binding affinity (DTA) prediction are improving the efficien cy of drug screening, but some limitations persist in current methodologies. Notably, ...

Abstract: Accurate detection of protein binding sites is critical for facilitating drug design. Most existing models rely on features at a single scale, leading to the loss of crucial global or local ...